Darapram
Brand names,
Darapram
Analogs
Darapram
Brand Names Mixture
- Fansidar Tablets (Pyrimethamine + Sulfadoxine)
- Quinnoxine-S (Pyrimethamine + Sulfaquinoxaline)
- Sulfaquinoxaline-S Liq (Pyrimethamine + Sulfaquinoxaline)
Darapram
Chemical_Formula
C12H13ClN4
Darapram
RX_link
http://www.rxlist.com/cgi/generic2/pyrime.htm
Darapram
fda sheet
Darapram
msds (material safety sheet)
Darapram
Synthesis Reference
Russel, Hitchings, J. Am. Chem. Soc. 73, 3763 (1951); Hitchings et al., U.S. pats. 2,576,939; 2,579,259, and 2,602,794 (1951 and 1952 to Burroughs Wellcome); Jacob, U.S. pat 2,680,740 (1954 to Rhone-Poulenc)
Darapram
Molecular Weight
248.711 g/mol
Darapram
Melting Point
233.5 oC
Darapram
H2O Solubility
121 mg/L
Darapram
State
Solid
Darapram
LogP
2.607
Darapram
Dosage Forms
Tablet
Darapram
Indication
For the treatment of toxoplasmosis and acute malaria; For the prevention of malaria in areas non-resistant to pyrimethamine
Darapram
Pharmacology
Pyrimethamine is an antiparasitic compound commonly used as an adjunct in the treatment of uncomplicated, chloroquine resistant, P. falciparum malaria. Pyrimethamine is a folic acid antagonist and the rationale for its therapeutic action is based on the differential requirement between host and parasite for nucleic acid precursors involved in growth. This activity is highly selective against plasmodia and Toxoplasma gondii. Pyrimethamine possesses blood schizonticidal and some tissue schizonticidal activity against malaria parasites of humans. However, the 4-amino-quinoline compounds are more effective against the erythrocytic schizonts. It does not destroy gametocytes, but arrests sporogony in the mosquito. The action of pyrimethamine against Toxoplasma gondii is greatly enhanced when used in conjunction with sulfonamides.
Darapram
Absorption
Well absorbed with peak levels occurring between 2 to 6 hours following administration
Darapram
side effects and Toxicity
No information avaliable
Darapram
Patient Information
Darapram
Organisms Affected
Plasmodium